retatrutide glp1 a 40mg Pen | Triple G Weight Management | Premio Peptides 🎙️ NEW EPISODE: Retatrutide—The Triple

No controlled human trial has ever defined a subcutaneous or intramuscular GHK-Cu dose for any endpoint, and no injectable GHK-Cu product is approved anywhere

While several compounds are promoted via social media claiming benefits of tissue repair, skin rejuvenation and anti-aging, we are particularly alarmed by the number of patients in our public multidisciplinary obesity clinic admitting to the use of unregulated products for weight loss, presumed to be pharmaceutical grade glucagon-like peptide-1 receptor agonists (GLP-1RA)

We make this process simple and accessible through our telehealth-first model

Because it focuses exclusively on domestic drugmakers, it has high concentration in its top two holdings